FlawCheck Citator
Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10372933
United States Court of Appeals for the Ninth Circuit

United States v. Siao

No. 10372933 · Decided April 4, 2025
No. 10372933 · Ninth Circuit · 2025 · FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
April 4, 2025
Citation
No. 10372933
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 4 2025 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT UNITED STATES OF AMERICA, No. 24-1486 D.C. No. Plaintiff - Appellee, 5:21-cr-00267-BLF-1 v. MEMORANDUM* DONALD SIAO, Defendant - Appellant. Appeal from the United States District Court for the Northern District of California Beth Labson Freeman, District Judge, Presiding Submitted April 2, 2025** San Francisco, California Before: HURWITZ, KOH, and JOHNSTONE, Circuit Judges. Donald Siao appeals his conviction under 21 U.S.C. § 841(a)(1) for the unauthorized distribution of a controlled substance. We have jurisdiction under 28 U.S.C. § 1291. Because the parties are familiar with the facts, we do not recount * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). them here, except as necessary to provide context to our ruling. Siao’s sole claim of error involves a jury instruction to which he did not object at trial. When there is no objection to a jury instruction at trial, we review for plain error. See United States v. Conti, 804 F.3d 977, 981 (9th Cir. 2015). Under the plain error standard, relief is not warranted unless there has been an error, that was plain, which affected the defendant’s substantial rights, and “seriously affected the fairness, integrity, or public reputation of judicial proceedings.” United States v. Walter-Eze, 869 F.3d 891, 911 (9th Cir. 2017). Finding no plain error, we affirm. “Except as authorized,” it is “unlawful for any person knowingly or intentionally—to manufacture, distribute, or dispense . . . a controlled substance.” 21 U.S.C. § 841(a)(1). Conduct is unauthorized if it is not “issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.” 21 C.F.R. § 1306.04(a). “After a defendant produces evidence that he or she was authorized to dispense controlled substances, the Government must prove beyond a reasonable doubt that the defendant knew that he or she was acting in an unauthorized manner, or intended to do so.” Ruan v. United States, 597 U.S. 450, 454 (2022). In other words, the government must “prove not only that the conduct was unauthorized, but also that the defendant knew or intended it to be unauthorized.” United States v. Pham, 120 F.4th 1368, 2 24-1486 1371 (9th Cir. 2024) (citing Ruan, 597 U.S. at 468). The disputed jury instruction stated that to convict, the jury was required to find that: “Donald Siao knowingly or intentionally acted in an unauthorized manner. ‘Unauthorized manner’ means that the distribution of the controlled substance was outside of the usual course of professional practice and without a legitimate medical purpose.” Although the parties’ stipulated jury instruction may have more clearly conveyed the objective and subjective elements of unauthorized distribution, the given instruction sufficiently conveys the elements of § 841(a)(1) because it requires the jury to find both that Siao knowingly or intentionally acted in an unauthorized manner and that his actions were in fact unauthorized. See United States v. Feingold, 454 F.3d 1001, 1008-09 (9th Cir. 2006) (instructing which elements the government must prove, and suggesting that a similarly combined instruction would be sufficient). Any ambiguity in the instruction was not “clear or obvious” error and thus was not plain error. See Puckett v. United States, 556 U.S. 129, 135 (2009). AFFIRMED. 3 24-1486
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 4 2025 MOLLY C.
Key Points
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 4 2025 MOLLY C.
FlawCheck shows no negative treatment for United States v. Siao in the current circuit citation data.
This case was decided on April 4, 2025.
Use the citation No. 10372933 and verify it against the official reporter before filing.
Why Attorneys Choose FlawFinder

Why Attorneys Choose FlawFinder

Side-by-side with Westlaw and LexisNexis

Feature FlawFinder Westlaw LexisNexis
Monthly price$19 – $99$133 – $646$153 – $399
ContractNone1–3 year min1–6 year min
Hidden fees$0, alwaysUp to $469/search$25/mo + per-doc
FlawCheck citatorIncludedKeyCite ($$$)Shepard's ($$$)
Plain-English summaryIncludedNoNo
CancelOne clickTermination feesAccount friction
Related Cases

Full legal research for $19/month

All 50 states · Federal regulations · Case law · Police SOPs · AI analysis included · No contract

Continue Researching →